AstraZeneca and Cellworks announced a collaboration supported by the Wellcome Trust to speed the design of novel combination therapies for the treatment of drug-sensitive and resistant tuberculosis.

Tuberculosis (TB) is one of the scourges of humans, infecting about one-third of the world's population, or two billion people. It kills an estimated eight million people annually. And while a vaccine ...